Brief: Prelude Therapeutics Announces Pricing Of Upsized Public Offering
07/01/2021 05:28
Jan 7 (Reuters) - Prelude Therapeutics Inc PRLD.O :
* PRELUDE THERAPEUTICS ANNOUNCES PRICING OF UPSIZED PUBLIC
OFFERING
* PRELUDE THERAPEUTICS-PRICED UPSIZED PUBLIC OFFERING OF 2.2
MILLION SHARES OF VOTING STOCK & 291,666 SHARES OF NON-VOTING
STOCK EACH AT $60PER SHARE
Source text for Eikon: ID:nGNX9ZXTr0
Further company coverage: PRLD.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Prelude Therapeutics Incorporated
See all newsBrief: Prelude Announces Clinical Trial Collaboration And Supply Agreement With Lilly To Evaluate KAT6A Selective Degrader PRT13722 In Combination With Verzenio® And Inluriyo® In Patients With HR+/HER2- Breast Cancer
U.S. RESEARCH ROUNDUP-Celcuity, Fluence Energy, Salesforce
Prelude Therapeutics Incorporated reports results for the quarter ended June 30 - Earnings Summary
Prelude Therapeutics Q2 revenue beats analyst expectations, net loss narrows
Prelude Therapeutics Incorporated expected to post a loss of 20 cents a share - Earnings Preview